TY - JOUR
T1 - Crystal structures of hereditary vitamin D-resistant rickets-associated vitamin D receptor mutants R270l and W282R bound to 1,25-dihydroxyvitamin D 3 and synthetic ligands
AU - Nakabayashi, Makoto
AU - Tsukahara, Yoshito
AU - Iwasaki-Miyamoto, Yukiko
AU - Mihori-Shimazaki, Mika
AU - Yamada, Sachiko
AU - Inaba, Satomi
AU - Oda, Masayuki
AU - Shimizu, Masato
AU - Makishima, Makoto
AU - Tokiwa, Hiroaki
AU - Ikura, Teikichi
AU - Ito, Nobutoshi
PY - 2013/9/12
Y1 - 2013/9/12
N2 - The vitamin D receptor (VDR), a member of the nuclear receptor superfamily, functions as a ligand-dependent transcription factor for various genes. Hereditary vitamin D-resistant rickets (HVDRR), an autosomal recessive disease, is caused by mutations in the VDR. In particular, the missense mutations R274L and W286R in the ligand-binding domain of the VDR can severely reduce or even eliminate natural hormone responsiveness. Here, we report a crystal structure analysis of the R270L and W282R mutants of rat VDR (human R274L and W286R, respectively) in complex with the natural hormone and synthetic ligands. We also studied the folding properties of the mutant proteins by using circular dichroism spectra. Our study indicates that these mutations result in only local structural modifications. We discuss why these mutations disrupt the VDR function and provide clues to develop effective ligands for the treatment of HVDRR.
AB - The vitamin D receptor (VDR), a member of the nuclear receptor superfamily, functions as a ligand-dependent transcription factor for various genes. Hereditary vitamin D-resistant rickets (HVDRR), an autosomal recessive disease, is caused by mutations in the VDR. In particular, the missense mutations R274L and W286R in the ligand-binding domain of the VDR can severely reduce or even eliminate natural hormone responsiveness. Here, we report a crystal structure analysis of the R270L and W282R mutants of rat VDR (human R274L and W286R, respectively) in complex with the natural hormone and synthetic ligands. We also studied the folding properties of the mutant proteins by using circular dichroism spectra. Our study indicates that these mutations result in only local structural modifications. We discuss why these mutations disrupt the VDR function and provide clues to develop effective ligands for the treatment of HVDRR.
UR - http://www.scopus.com/inward/record.url?scp=84884247009&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84884247009&partnerID=8YFLogxK
U2 - 10.1021/jm400537h
DO - 10.1021/jm400537h
M3 - Article
C2 - 23944708
AN - SCOPUS:84884247009
SN - 0022-2623
VL - 56
SP - 6745
EP - 6760
JO - Journal of medicinal chemistry
JF - Journal of medicinal chemistry
IS - 17
ER -